In 1910, German scientist Paul Ehrlich introduced a groundbreaking concept to the world: chemical compounds could be engineered to interact
Continue Reading Key Patent Considerations for Antibody Drug Conjugates (ADCs)
CTA Update: Domestic Reporting Companies Exempt from Reporting to FinCEN
Although the Corporate Transparency Act (the “CTA”) is no longer halted by nationwide preliminary injunctions, U.S. companies and their beneficial
Continue Reading CTA Update: Domestic Reporting Companies Exempt from Reporting to FinCEN
Corporate Transparency Act Requirements Are Back: March 21, 2025 Deadline Looms
For the past few months, the beneficial ownership reporting obligations under the Corporate Transparency Act (the “CTA”) have fluctuated between
Continue Reading Corporate Transparency Act Requirements Are Back: March 21, 2025 Deadline Looms
CRISPR and Agriculture
Co-authored by Sheena Wang and Ellie Purnell of HGF limited, “CRISPR and Agriculture” was originally published by Food and Drink
Continue Reading CRISPR and Agriculture
Latest Update: Corporate Transparency Act Halted Again
Only days after lifting the nationwide preliminary injunction, the Fifth Circuit Court of Appeals vacated their decision to stay the
Continue Reading Latest Update: Corporate Transparency Act Halted Again
Update: Corporate Transparency Act Reinstated by Appeals Court: January 1 Deadline Looms
As an update to our posts on the ongoing attempts to block the Corporate Transparency Act, on December 23, 2024
Continue Reading Update: Corporate Transparency Act Reinstated by Appeals Court: January 1 Deadline Looms
Update: The Corporate Transparency Act Put On Hold
As an update to our post on the Corporate Transparency Act, on December 3, 2024, a federal district court issued
Continue Reading Update: The Corporate Transparency Act Put On Hold
USPTO Finalizes Fee Increases for 2025: What to Expect in the New Year and What to do Now
The United States Patent and Trademark Office (USPTO) announced today the finalized fee increases taking effect on January 19, 2025.
Continue Reading USPTO Finalizes Fee Increases for 2025: What to Expect in the New Year and What to do Now
Key Inventorship Considerations in AI-assisted Drug Development
The utilization of artificial intelligence (“AI”) is becoming ubiquitous across a wide range of industry sectors. The biotech industry is
Continue Reading Key Inventorship Considerations in AI-assisted Drug Development
The Future of Food: Regulatory and Patent Landscape of Genome Editing in Food Technology
Our current food system is facing a myriad of critical challenges. The United Nations predicts that the world population will
Continue Reading The Future of Food: Regulatory and Patent Landscape of Genome Editing in Food Technology